Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Debt Ratio (2020 - 2025)

Historic Debt Ratio for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to 0.29.

  • Eton Pharmaceuticals' Debt Ratio rose 15246.44% to 0.29 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.29, marking a year-over-year increase of 15246.44%. This contributed to the annual value of 0.39 for FY2024, which is 13103.9% up from last year.
  • As of Q3 2025, Eton Pharmaceuticals' Debt Ratio stood at 0.29, which was up 15246.44% from 0.3 recorded in Q2 2025.
  • Eton Pharmaceuticals' 5-year Debt Ratio high stood at 0.39 for Q4 2024, and its period low was 0.01 during Q1 2021.
  • Its 5-year average for Debt Ratio is 0.11, with a median of 0.05 in 2021.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Debt Ratio surged by 38529.74% in 2021, and later tumbled by 3693.59% in 2022.
  • Quarter analysis of 5 years shows Eton Pharmaceuticals' Debt Ratio stood at 0.05 in 2021, then fell by 20.06% to 0.04 in 2022, then soared by 310.71% to 0.17 in 2023, then skyrocketed by 131.04% to 0.39 in 2024, then decreased by 25.8% to 0.29 in 2025.
  • Its Debt Ratio was 0.29 in Q3 2025, compared to 0.3 in Q2 2025 and 0.39 in Q4 2024.